Spots Global Cancer Trial Database for daunorubicine
Every month we try and update this database with for daunorubicine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients | NCT00219765 | Chronic Myeloid... | Imatinib mesyla... Cytarabine Daunorubicine | 18 Years - | Poitiers University Hospital | |
AML Treatment in Untreated Adult Patients | NCT00449319 | Leukemia, Myelo... | Identification ... Daunorubicine Transplant | 15 Years - 61 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
AML Treatment in Untreated Adult Patients | NCT00449319 | Leukemia, Myelo... | Identification ... Daunorubicine Transplant | 15 Years - 61 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto |